

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.32576915 |
| 2 | urate metabolic process (GO:0046415) | 6.03523865 |
| 3 | regulation of cholesterol esterification (GO:0010872) | 6.00470924 |
| 4 | plasma lipoprotein particle assembly (GO:0034377) | 5.95142804 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.79684767 |
| 6 | drug transport (GO:0015893) | 5.57921770 |
| 7 | protein-lipid complex assembly (GO:0065005) | 5.44590238 |
| 8 | phospholipid efflux (GO:0033700) | 5.36594781 |
| 9 | cholesterol efflux (GO:0033344) | 5.26818088 |
| 10 | cysteine metabolic process (GO:0006534) | 5.08116210 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 5.05445610 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 5.01000545 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 5.01000545 |
| 14 | lysine metabolic process (GO:0006553) | 4.97800450 |
| 15 | lysine catabolic process (GO:0006554) | 4.97800450 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.93506233 |
| 17 | * oligosaccharide catabolic process (GO:0009313) | 4.78997422 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.68790322 |
| 19 | plasma lipoprotein particle clearance (GO:0034381) | 4.67660350 |
| 20 | glycolipid catabolic process (GO:0019377) | 4.67428484 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.55766836 |
| 22 | phosphate ion transport (GO:0006817) | 4.51396846 |
| 23 | organic cation transport (GO:0015695) | 4.33477983 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.29467347 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.27167650 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 4.27167650 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.23430534 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 4.23430534 |
| 29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.17352789 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 4.12636772 |
| 31 | macromolecular complex remodeling (GO:0034367) | 4.12636772 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12636772 |
| 33 | ceramide catabolic process (GO:0046514) | 4.09537972 |
| 34 | drug catabolic process (GO:0042737) | 4.08318999 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01892903 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 4.01174283 |
| 37 | low-density lipoprotein particle clearance (GO:0034383) | 4.01117989 |
| 38 | plasma lipoprotein particle organization (GO:0071827) | 3.99347988 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.99186662 |
| 40 | protein carboxylation (GO:0018214) | 3.91591133 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.91591133 |
| 42 | response to mercury ion (GO:0046689) | 3.91389554 |
| 43 | intestinal cholesterol absorption (GO:0030299) | 3.91069305 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 3.88445277 |
| 45 | phosphate ion transmembrane transport (GO:0035435) | 3.84796305 |
| 46 | exogenous drug catabolic process (GO:0042738) | 3.84237651 |
| 47 | protein-lipid complex subunit organization (GO:0071825) | 3.83640213 |
| 48 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.79310104 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 3.78300357 |
| 50 | valine metabolic process (GO:0006573) | 3.76711914 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 3.75043298 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73847675 |
| 53 | homocysteine metabolic process (GO:0050667) | 3.73536246 |
| 54 | sphingolipid catabolic process (GO:0030149) | 3.70962570 |
| 55 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.66387288 |
| 56 | quaternary ammonium group transport (GO:0015697) | 3.62778765 |
| 57 | negative regulation of sterol transport (GO:0032372) | 3.61685733 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 3.61685733 |
| 59 | membrane lipid catabolic process (GO:0046466) | 3.60242683 |
| 60 | tryptophan catabolic process (GO:0006569) | 3.56741623 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 3.56741623 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 3.56741623 |
| 63 | protein maturation by protein folding (GO:0022417) | 3.53792361 |
| 64 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.50838793 |
| 65 | glutathione biosynthetic process (GO:0006750) | 3.49555888 |
| 66 | toxin transport (GO:1901998) | 3.49437109 |
| 67 | vitamin D metabolic process (GO:0042359) | 3.48312841 |
| 68 | glycoside metabolic process (GO:0016137) | 3.44076912 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.43942208 |
| 70 | tryptophan metabolic process (GO:0006568) | 3.42958319 |
| 71 | aspartate family amino acid catabolic process (GO:0009068) | 3.42330799 |
| 72 | branched-chain amino acid metabolic process (GO:0009081) | 3.42192275 |
| 73 | cholesterol transport (GO:0030301) | 3.39573609 |
| 74 | sterol transport (GO:0015918) | 3.39573609 |
| 75 | protein retention in ER lumen (GO:0006621) | 3.35748336 |
| 76 | excretion (GO:0007588) | 3.33410520 |
| 77 | negative regulation of lipase activity (GO:0060192) | 3.27561127 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27541632 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27541632 |
| 80 | fructose metabolic process (GO:0006000) | 3.27305329 |
| 81 | amino-acid betaine metabolic process (GO:0006577) | 3.27047329 |
| 82 | modified amino acid transport (GO:0072337) | 3.26946200 |
| 83 | positive regulation of steroid metabolic process (GO:0045940) | 3.24700736 |
| 84 | lipoprotein metabolic process (GO:0042157) | 3.23702272 |
| 85 | renal absorption (GO:0070293) | 3.23464838 |
| 86 | serine family amino acid catabolic process (GO:0009071) | 3.23312233 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 3.20395357 |
| 88 | peptide catabolic process (GO:0043171) | 3.20138013 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.17875994 |
| 90 | fatty acid oxidation (GO:0019395) | 3.17226809 |
| 91 | cellular copper ion homeostasis (GO:0006878) | 3.14650125 |
| 92 | lipid oxidation (GO:0034440) | 3.14464056 |
| 93 | amyloid precursor protein catabolic process (GO:0042987) | 3.13509737 |
| 94 | amino sugar catabolic process (GO:0046348) | 3.13014340 |
| 95 | alpha-linolenic acid metabolic process (GO:0036109) | 3.12936366 |
| 96 | kynurenine metabolic process (GO:0070189) | 3.11470167 |
| 97 | intestinal absorption (GO:0050892) | 3.09543672 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.09465980 |
| 99 | sterol homeostasis (GO:0055092) | 3.08700853 |
| 100 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.06204652 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.05898958 |
| 102 | negative regulation of fibrinolysis (GO:0051918) | 3.05830523 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.04090327 |
| 104 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.01199850 |
| 105 | aromatic amino acid family metabolic process (GO:0009072) | 2.99648202 |
| 106 | vitamin transport (GO:0051180) | 2.97077417 |
| 107 | glutamate metabolic process (GO:0006536) | 2.96904296 |
| 108 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.96658083 |
| 109 | regulation of extracellular matrix disassembly (GO:0010715) | 2.96210502 |
| 110 | COPII vesicle coating (GO:0048208) | 2.90620552 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.90216010 |
| 112 | regulation of superoxide anion generation (GO:0032928) | 2.90081162 |
| 113 | regulation of protein activation cascade (GO:2000257) | 2.88994181 |
| 114 | regulation of cholesterol storage (GO:0010885) | 2.88837290 |
| 115 | cellular amino acid catabolic process (GO:0009063) | 2.88317526 |
| 116 | transferrin transport (GO:0033572) | 2.85890996 |
| 117 | glucose 6-phosphate metabolic process (GO:0051156) | 2.82855870 |
| 118 | branched-chain amino acid catabolic process (GO:0009083) | 2.81872004 |
| 119 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.80946622 |
| 120 | cellular ketone body metabolic process (GO:0046950) | 2.80656905 |
| 121 | regulation of fibrinolysis (GO:0051917) | 2.80326893 |
| 122 | 4-hydroxyproline metabolic process (GO:0019471) | 2.80162016 |
| 123 | glutathione metabolic process (GO:0006749) | 2.77276932 |
| 124 | response to thyroid hormone (GO:0097066) | 2.77264756 |
| 125 | carnitine metabolic process (GO:0009437) | 2.76596681 |
| 126 | peptide biosynthetic process (GO:0043043) | 2.76419157 |
| 127 | flavonoid metabolic process (GO:0009812) | 2.75771737 |
| 128 | acetyl-CoA metabolic process (GO:0006084) | 2.73972478 |
| 129 | L-ascorbic acid metabolic process (GO:0019852) | 2.73672116 |
| 130 | proline biosynthetic process (GO:0006561) | 2.73081055 |
| 131 | NADP metabolic process (GO:0006739) | 2.72763067 |
| 132 | alpha-amino acid catabolic process (GO:1901606) | 2.72711233 |
| 133 | proline metabolic process (GO:0006560) | 2.72567811 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.72535717 |
| 135 | keratan sulfate catabolic process (GO:0042340) | 2.72087152 |
| 136 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.71462291 |
| 137 | pentose-phosphate shunt (GO:0006098) | 2.71210003 |
| 138 | carboxylic acid catabolic process (GO:0046395) | 2.70709037 |
| 139 | organic acid catabolic process (GO:0016054) | 2.70709037 |
| 140 | monocarboxylic acid catabolic process (GO:0072329) | 2.70084104 |
| 141 | macroautophagy (GO:0016236) | 2.69821939 |
| 142 | sulfur compound transport (GO:0072348) | 2.69539686 |
| 143 | pinocytosis (GO:0006907) | 2.69414963 |
| 144 | NADPH regeneration (GO:0006740) | 2.68902224 |
| 145 | regulation of complement activation (GO:0030449) | 2.68088913 |
| 146 | cellular zinc ion homeostasis (GO:0006882) | 2.66846099 |
| 147 | trivalent inorganic anion homeostasis (GO:0072506) | 2.65912578 |
| 148 | phosphate ion homeostasis (GO:0055062) | 2.65912578 |
| 149 | negative regulation of protein activation cascade (GO:2000258) | 2.64697352 |
| 150 | indolalkylamine metabolic process (GO:0006586) | 2.63904905 |
| 151 | glutathione derivative biosynthetic process (GO:1901687) | 2.62967824 |
| 152 | glutathione derivative metabolic process (GO:1901685) | 2.62967824 |
| 153 | uronic acid metabolic process (GO:0006063) | 2.62073175 |
| 154 | glucuronate metabolic process (GO:0019585) | 2.62073175 |
| 155 | regulation of metalloenzyme activity (GO:0048552) | 2.61268627 |
| 156 | ferric iron transport (GO:0015682) | 2.60968872 |
| 157 | trivalent inorganic cation transport (GO:0072512) | 2.60968872 |
| 158 | beta-amyloid metabolic process (GO:0050435) | 2.60579497 |
| 159 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.60260245 |
| 160 | GDP-mannose metabolic process (GO:0019673) | 2.60090540 |
| 161 | amino-acid betaine transport (GO:0015838) | 2.58770758 |
| 162 | carnitine transport (GO:0015879) | 2.58770758 |
| 163 | lysosome organization (GO:0007040) | 2.57934519 |
| 164 | lytic vacuole organization (GO:0080171) | 2.57934519 |
| 165 | cholesterol metabolic process (GO:0008203) | 2.57258980 |
| 166 | drug metabolic process (GO:0017144) | 2.57249670 |
| 167 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.56733905 |
| 168 | bile acid and bile salt transport (GO:0015721) | 2.56115244 |
| 169 | NADH metabolic process (GO:0006734) | 2.52414595 |
| 170 | aldehyde catabolic process (GO:0046185) | 2.52052391 |
| 171 | N-acetylneuraminate metabolic process (GO:0006054) | 2.51932286 |
| 172 | serine family amino acid biosynthetic process (GO:0009070) | 2.51724309 |
| 173 | phospholipid homeostasis (GO:0055091) | 2.51486588 |
| 174 | positive regulation of hormone metabolic process (GO:0032352) | 2.51372775 |
| 175 | regulation of cholesterol metabolic process (GO:0090181) | 2.50238490 |
| 176 | benzene-containing compound metabolic process (GO:0042537) | 2.50132851 |
| 177 | response to growth hormone (GO:0060416) | 2.49945468 |
| 178 | bile acid biosynthetic process (GO:0006699) | 2.49658113 |
| 179 | triglyceride homeostasis (GO:0070328) | 2.49645933 |
| 180 | acylglycerol homeostasis (GO:0055090) | 2.49645933 |
| 181 | vitamin transmembrane transport (GO:0035461) | 2.49288405 |
| 182 | cholesterol biosynthetic process (GO:0006695) | 2.49257950 |
| 183 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.48675844 |
| 184 | ketone body metabolic process (GO:1902224) | 2.48342858 |
| 185 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48060457 |
| 186 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48060457 |
| 187 | cellular glucuronidation (GO:0052695) | 2.47169313 |
| 188 | indole-containing compound metabolic process (GO:0042430) | 2.47026525 |
| 189 | metanephric nephron tubule development (GO:0072234) | 2.46385976 |
| 190 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.46339045 |
| 191 | apoptotic cell clearance (GO:0043277) | 2.45379160 |
| 192 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.44307750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.93664673 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66145317 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.19821751 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.66049883 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53876600 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.77923826 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75976587 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.57726851 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.48260555 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.36733834 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34268337 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.27045913 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23948759 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.17778424 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05329196 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04932474 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03237364 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97646592 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92553621 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.92152056 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91641074 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90771647 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89943992 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88949427 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.88150317 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86640002 |
| 27 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.85363096 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83843838 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83226075 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82250350 |
| 31 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81905031 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71956837 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.68303899 |
| 34 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.68147338 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.63543903 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63016193 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60705863 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58205611 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56970106 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55592826 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53414199 |
| 42 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52486437 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49545057 |
| 44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48801000 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44957903 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43195706 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39197927 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38657606 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37464037 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37196472 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31252864 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29918486 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28817462 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28255158 |
| 55 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24615307 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21782000 |
| 57 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21767199 |
| 58 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.21270822 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21205022 |
| 60 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18056050 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17363975 |
| 62 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16429829 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12294612 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12057789 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11573363 |
| 66 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11240760 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09308903 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08946915 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08448491 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08305825 |
| 71 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08123168 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07804029 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07796315 |
| 74 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07492209 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06827230 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05221595 |
| 77 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04772358 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04538170 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04375366 |
| 80 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03711759 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03126315 |
| 82 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.02979536 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.01730019 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01674448 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00883840 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00476382 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99880667 |
| 88 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99461284 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99448687 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99406368 |
| 91 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99237228 |
| 92 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99080074 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98866148 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98768133 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98368708 |
| 96 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98209987 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97802742 |
| 98 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.97279509 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97181632 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96531488 |
| 101 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96222683 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96146351 |
| 103 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95392883 |
| 104 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95338515 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95336190 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95216409 |
| 107 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95159030 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95054787 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94218896 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94180402 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94018909 |
| 112 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93822776 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93822547 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93578820 |
| 115 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93367971 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92879314 |
| 117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92629137 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92592109 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92003597 |
| 120 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91855352 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91136215 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88964443 |
| 123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88960852 |
| 124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.88877643 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88838793 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88816789 |
| 127 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88447541 |
| 128 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88442507 |
| 129 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88266900 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87699216 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86561600 |
| 132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86339973 |
| 133 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86059651 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84185784 |
| 135 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83258964 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83240089 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82332235 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82312521 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.82182237 |
| 140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82059673 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81820191 |
| 142 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80465330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.71177493 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.58823271 |
| 3 | MP0004043_abnormal_pH_regulation | 3.71062411 |
| 4 | * MP0005058_abnormal_lysosome_morphology | 3.49977642 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.36093572 |
| 6 | MP0005332_abnormal_amino_acid | 3.34374002 |
| 7 | MP0003195_calcinosis | 3.18584716 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.02828887 |
| 9 | * MP0009643_abnormal_urine_homeostasis | 2.98928552 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.83703111 |
| 11 | MP0005365_abnormal_bile_salt | 2.76356995 |
| 12 | MP0002254_reproductive_system_inflammat | 2.72339845 |
| 13 | MP0001765_abnormal_ion_homeostasis | 2.66777027 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.54224687 |
| 15 | MP0009840_abnormal_foam_cell | 2.54115776 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.48185196 |
| 17 | MP0001756_abnormal_urination | 2.36073173 |
| 18 | MP0005636_abnormal_mineral_homeostasis | 2.31202185 |
| 19 | MP0003252_abnormal_bile_duct | 2.22816145 |
| 20 | MP0002136_abnormal_kidney_physiology | 2.07384529 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.05515166 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.00871110 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.93659754 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.92455568 |
| 25 | MP0005408_hypopigmentation | 1.85656084 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 1.79836211 |
| 27 | MP0003878_abnormal_ear_physiology | 1.79836211 |
| 28 | MP0004272_abnormal_basement_membrane | 1.77083692 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.64991229 |
| 30 | MP0003123_paternal_imprinting | 1.63984848 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.57122942 |
| 32 | MP0000604_amyloidosis | 1.54941838 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.49912518 |
| 34 | MP0003186_abnormal_redox_activity | 1.48170673 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.47622329 |
| 36 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.45432183 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.41087705 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.37939426 |
| 39 | MP0003436_decreased_susceptibility_to | 1.35611665 |
| 40 | MP0006082_CNS_inflammation | 1.35393874 |
| 41 | MP0005083_abnormal_biliary_tract | 1.35256370 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.35119990 |
| 43 | MP0003724_increased_susceptibility_to | 1.34058877 |
| 44 | MP0000609_abnormal_liver_physiology | 1.33567097 |
| 45 | MP0003329_amyloid_beta_deposits | 1.33444816 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.30615871 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.29854033 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.27442250 |
| 49 | MP0006054_spinal_hemorrhage | 1.26541898 |
| 50 | MP0005310_abnormal_salivary_gland | 1.25946576 |
| 51 | * MP0008469_abnormal_protein_level | 1.25798048 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.19423920 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.19190240 |
| 54 | MP0002419_abnormal_innate_immunity | 1.17486654 |
| 55 | MP0003303_peritoneal_inflammation | 1.17075787 |
| 56 | MP0003866_abnormal_defecation | 1.16697903 |
| 57 | MP0000343_altered_response_to | 1.15893831 |
| 58 | MP0005451_abnormal_body_composition | 1.14786604 |
| 59 | MP0001958_emphysema | 1.14073221 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.13311554 |
| 61 | MP0009764_decreased_sensitivity_to | 1.12409631 |
| 62 | MP0003122_maternal_imprinting | 1.11270981 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.10652526 |
| 64 | MP0003075_altered_response_to | 1.10497748 |
| 65 | MP0000371_diluted_coat_color | 1.08773512 |
| 66 | MP0009785_altered_susceptibility_to | 1.07231777 |
| 67 | MP0005670_abnormal_white_adipose | 1.06246544 |
| 68 | MP0003879_abnormal_hair_cell | 1.05033819 |
| 69 | MP0005164_abnormal_response_to | 1.03986509 |
| 70 | MP0001764_abnormal_homeostasis | 1.03809598 |
| 71 | MP0000858_altered_metastatic_potential | 1.03673567 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.02015776 |
| 73 | MP0002090_abnormal_vision | 1.01803181 |
| 74 | MP0001873_stomach_inflammation | 0.99199556 |
| 75 | MP0001835_abnormal_antigen_presentation | 0.97883841 |
| 76 | MP0005025_abnormal_response_to | 0.96810630 |
| 77 | MP0002928_abnormal_bile_duct | 0.96361128 |
| 78 | * MP0009642_abnormal_blood_homeostasis | 0.96353141 |
| 79 | MP0005387_immune_system_phenotype | 0.95805858 |
| 80 | MP0001790_abnormal_immune_system | 0.95805858 |
| 81 | MP0005535_abnormal_body_temperature | 0.94763372 |
| 82 | MP0005000_abnormal_immune_tolerance | 0.94359876 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.94025984 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.93214060 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.92650674 |
| 86 | MP0003690_abnormal_glial_cell | 0.91056910 |
| 87 | MP0004233_abnormal_muscle_weight | 0.90958948 |
| 88 | MP0001853_heart_inflammation | 0.90663338 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.90122148 |
| 90 | MP0005166_decreased_susceptibility_to | 0.89492497 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.88961734 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.87698054 |
| 93 | MP0001663_abnormal_digestive_system | 0.87397320 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.85766210 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 0.83890980 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.83417892 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.83300811 |
| 98 | MP0003868_abnormal_feces_composition | 0.82796062 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.82592907 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.82037419 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.81267357 |
| 102 | * MP0002135_abnormal_kidney_morphology | 0.81210333 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.80034860 |
| 104 | MP0005023_abnormal_wound_healing | 0.79828314 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.78792329 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.78334941 |
| 107 | MP0000920_abnormal_myelination | 0.77876015 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.76732731 |
| 109 | MP0004947_skin_inflammation | 0.75543304 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.75182451 |
| 111 | MP0005165_increased_susceptibility_to | 0.75033236 |
| 112 | MP0001661_extended_life_span | 0.74693443 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.74639886 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.74472840 |
| 115 | * MP0000598_abnormal_liver_morphology | 0.73475447 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.72655175 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.72441728 |
| 118 | MP0001915_intracranial_hemorrhage | 0.71802266 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.71014507 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.70033080 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.69049447 |
| 122 | MP0002723_abnormal_immune_serum | 0.68943586 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.68695892 |
| 124 | MP0002168_other_aberrant_phenotype | 0.67719556 |
| 125 | * MP0003634_abnormal_glial_cell | 0.66895313 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.66450023 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.66322445 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.65448983 |
| 129 | MP0000685_abnormal_immune_system | 0.64534487 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.63983071 |
| 131 | MP0008260_abnormal_autophagy | 0.63134735 |
| 132 | MP0004858_abnormal_nervous_system | 0.62318471 |
| 133 | MP0003795_abnormal_bone_structure | 0.61591452 |
| 134 | MP0001664_abnormal_digestion | 0.61563572 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.61248730 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.61145195 |
| 137 | MP0003632_abnormal_nervous_system | 0.58800241 |
| 138 | MP0001881_abnormal_mammary_gland | 0.52312466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 5.22763951 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 5.22629370 |
| 3 | Gout (HP:0001997) | 4.96661040 |
| 4 | Increased circulating renin level (HP:0000848) | 4.93362266 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 4.90919264 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 4.60494725 |
| 7 | Hypomagnesemia (HP:0002917) | 4.41477834 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.22819058 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 4.12760237 |
| 10 | Polyuria (HP:0000103) | 4.12635210 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12015499 |
| 12 | Proximal tubulopathy (HP:0000114) | 4.08419362 |
| 13 | Abnormal urine output (HP:0012590) | 4.01751519 |
| 14 | Abnormality of renal excretion (HP:0011036) | 3.87329614 |
| 15 | Abnormality of purine metabolism (HP:0004352) | 3.79905052 |
| 16 | Hyperglycinuria (HP:0003108) | 3.78800900 |
| 17 | Alkalosis (HP:0001948) | 3.76746090 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.73205412 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.58348692 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.54095242 |
| 21 | Abnormality of renin-angiotensin system (HP:0000847) | 3.53804340 |
| 22 | Loss of speech (HP:0002371) | 3.52801763 |
| 23 | * Vacuolated lymphocytes (HP:0001922) | 3.48758464 |
| 24 | Hyperuricemia (HP:0002149) | 3.47419327 |
| 25 | Increased purine levels (HP:0004368) | 3.47419327 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.44085610 |
| 27 | Ketoacidosis (HP:0001993) | 3.37971196 |
| 28 | Mucopolysacchariduria (HP:0008155) | 3.37166482 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.37166482 |
| 30 | Prolonged neonatal jaundice (HP:0006579) | 3.33303729 |
| 31 | Hyperaldosteronism (HP:0000859) | 3.32544629 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32317755 |
| 33 | Abnormal drinking behavior (HP:0030082) | 3.32030267 |
| 34 | Polydipsia (HP:0001959) | 3.32030267 |
| 35 | * Dysostosis multiplex (HP:0000943) | 3.29660359 |
| 36 | Tetany (HP:0001281) | 3.29632999 |
| 37 | Ketosis (HP:0001946) | 3.23594410 |
| 38 | Neurofibrillary tangles (HP:0002185) | 3.21831389 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.18517256 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18126948 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18126948 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18126948 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.09568884 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 3.09568884 |
| 45 | Hypokinesia (HP:0002375) | 3.09487911 |
| 46 | Amyloidosis (HP:0011034) | 3.08538666 |
| 47 | Hypolipoproteinemia (HP:0010981) | 3.07737874 |
| 48 | Glomerulonephritis (HP:0000099) | 3.06866510 |
| 49 | Renal salt wasting (HP:0000127) | 3.02225075 |
| 50 | Retinal atrophy (HP:0001105) | 2.98634836 |
| 51 | Xanthomatosis (HP:0000991) | 2.97807511 |
| 52 | Myocardial infarction (HP:0001658) | 2.96217690 |
| 53 | Abnormality of urine glucose concentration (HP:0011016) | 2.91060717 |
| 54 | Glycosuria (HP:0003076) | 2.91060717 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90864869 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.85918710 |
| 57 | Malnutrition (HP:0004395) | 2.84101981 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.82863798 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.82863798 |
| 60 | Nuclear cataract (HP:0100018) | 2.79204460 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.74821268 |
| 62 | Hypokalemia (HP:0002900) | 2.72520732 |
| 63 | J-shaped sella turcica (HP:0002680) | 2.71004506 |
| 64 | Complement deficiency (HP:0004431) | 2.70966682 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.62088896 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62025557 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62025557 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62025557 |
| 69 | Hypophosphatemia (HP:0002148) | 2.61272210 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.56715101 |
| 71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56255395 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.55354194 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.52379999 |
| 74 | Hyperammonemia (HP:0001987) | 2.52349559 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.52142626 |
| 76 | Axonal loss (HP:0003447) | 2.51633536 |
| 77 | Mitral stenosis (HP:0001718) | 2.51603164 |
| 78 | Gingival bleeding (HP:0000225) | 2.51472769 |
| 79 | Spontaneous abortion (HP:0005268) | 2.50433263 |
| 80 | Vascular calcification (HP:0004934) | 2.40706529 |
| 81 | Late onset (HP:0003584) | 2.38887125 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.37131748 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.37030676 |
| 84 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.36214325 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.35380406 |
| 86 | Renal tubular acidosis (HP:0001947) | 2.34389474 |
| 87 | Hyperglycinemia (HP:0002154) | 2.33638207 |
| 88 | Abnormal urine phosphate concentration (HP:0012599) | 2.33548722 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31724271 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.31724271 |
| 91 | * Cardiomegaly (HP:0001640) | 2.31505173 |
| 92 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.30031151 |
| 93 | Increased serum ferritin (HP:0003281) | 2.29306787 |
| 94 | * Abnormality of macrophages (HP:0004311) | 2.27763503 |
| 95 | Purpura (HP:0000979) | 2.27591274 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.27552047 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.26643409 |
| 98 | Cervical subluxation (HP:0003308) | 2.24812430 |
| 99 | Tetraparesis (HP:0002273) | 2.24677530 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.24433220 |
| 101 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24154653 |
| 102 | Fat malabsorption (HP:0002630) | 2.24148052 |
| 103 | Intrahepatic cholestasis (HP:0001406) | 2.23990707 |
| 104 | Beaking of vertebral bodies (HP:0004568) | 2.23273559 |
| 105 | Nephrolithiasis (HP:0000787) | 2.21539817 |
| 106 | Hypercalciuria (HP:0002150) | 2.21481705 |
| 107 | Abnormality of potassium homeostasis (HP:0011042) | 2.20344560 |
| 108 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.19353476 |
| 109 | Abnormality of complement system (HP:0005339) | 2.15914384 |
| 110 | Skin nodule (HP:0200036) | 2.14998231 |
| 111 | Eczematoid dermatitis (HP:0000976) | 2.13821799 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13664154 |
| 113 | Abnormal tarsal ossification (HP:0008369) | 2.13481490 |
| 114 | Irritability (HP:0000737) | 2.09571318 |
| 115 | Vomiting (HP:0002013) | 2.05709447 |
| 116 | Protuberant abdomen (HP:0001538) | 2.04871510 |
| 117 | Cardiovascular calcification (HP:0011915) | 2.03863363 |
| 118 | Dehydration (HP:0001944) | 2.03541073 |
| 119 | Metaphyseal irregularity (HP:0003025) | 2.03348123 |
| 120 | Rickets (HP:0002748) | 2.02588279 |
| 121 | Metabolic acidosis (HP:0001942) | 2.02198203 |
| 122 | Elevated alkaline phosphatase (HP:0003155) | 2.01096723 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00079697 |
| 124 | Recurrent abscess formation (HP:0002722) | 1.98951774 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.97034422 |
| 126 | Paraparesis (HP:0002385) | 1.95991967 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.95897923 |
| 128 | Pancreatitis (HP:0001733) | 1.95800355 |
| 129 | Recurrent bacterial skin infections (HP:0005406) | 1.95389884 |
| 130 | Abdominal distention (HP:0003270) | 1.94387966 |
| 131 | Nausea (HP:0002018) | 1.94315045 |
| 132 | Steatorrhea (HP:0002570) | 1.93814031 |
| 133 | Delayed CNS myelination (HP:0002188) | 1.93059863 |
| 134 | Hyperlipoproteinemia (HP:0010980) | 1.92242210 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.91727837 |
| 136 | Cholecystitis (HP:0001082) | 1.91318723 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.91318723 |
| 138 | Epidermoid cyst (HP:0200040) | 1.91007772 |
| 139 | Lethargy (HP:0001254) | 1.90606110 |
| 140 | Joint hemorrhage (HP:0005261) | 1.86287450 |
| 141 | Bone pain (HP:0002653) | 1.85648714 |
| 142 | Flat acetabular roof (HP:0003180) | 1.84657635 |
| 143 | Pathologic fracture (HP:0002756) | 1.82399382 |
| 144 | Abnormality of the lumbar spine (HP:0100712) | 1.80864285 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 1.79343060 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.79073194 |
| 147 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79014739 |
| 148 | Adrenal overactivity (HP:0002717) | 1.78649532 |
| 149 | Nephrocalcinosis (HP:0000121) | 1.78061161 |
| 150 | Petechiae (HP:0000967) | 1.77959946 |
| 151 | Confusion (HP:0001289) | 1.74168252 |
| 152 | Abnormality of sodium homeostasis (HP:0010931) | 1.73123567 |
| 153 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.68087128 |
| 154 | Apathy (HP:0000741) | 1.68062403 |
| 155 | Interstitial pulmonary disease (HP:0006530) | 1.66223051 |
| 156 | Increased CSF protein (HP:0002922) | 1.65327617 |
| 157 | Disinhibition (HP:0000734) | 1.64999768 |
| 158 | Diminished motivation (HP:0000745) | 1.64778897 |
| 159 | Opisthotonus (HP:0002179) | 1.64078876 |
| 160 | Joint swelling (HP:0001386) | 1.63534232 |
| 161 | Neuronal loss in central nervous system (HP:0002529) | 1.62093810 |
| 162 | Flared iliac wings (HP:0002869) | 1.58867054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.17559918 |
| 2 | WNK3 | 4.20212815 |
| 3 | OXSR1 | 3.85650113 |
| 4 | MST1R | 3.49672120 |
| 5 | BCKDK | 3.26296472 |
| 6 | ERN1 | 3.13637764 |
| 7 | TAOK3 | 2.85067333 |
| 8 | IRAK3 | 2.36442087 |
| 9 | TRIB3 | 2.18393007 |
| 10 | MAP3K2 | 1.94775216 |
| 11 | STK39 | 1.87533964 |
| 12 | ICK | 1.86600869 |
| 13 | MAP2K2 | 1.85666011 |
| 14 | PIM2 | 1.79492055 |
| 15 | RIPK4 | 1.76693991 |
| 16 | FGFR3 | 1.76523048 |
| 17 | GRK6 | 1.75834106 |
| 18 | KSR2 | 1.74128037 |
| 19 | TAOK2 | 1.71509958 |
| 20 | EPHA2 | 1.69779357 |
| 21 | EPHB1 | 1.69489284 |
| 22 | MAP4K1 | 1.65884625 |
| 23 | FRK | 1.59755810 |
| 24 | MAPKAPK3 | 1.55528170 |
| 25 | MST4 | 1.53920667 |
| 26 | PBK | 1.53228132 |
| 27 | FGFR4 | 1.50897250 |
| 28 | MAP3K13 | 1.49327949 |
| 29 | BLK | 1.47901602 |
| 30 | TBK1 | 1.44523861 |
| 31 | INSRR | 1.42476333 |
| 32 | CAMKK2 | 1.39169918 |
| 33 | DDR2 | 1.36209653 |
| 34 | CDK12 | 1.35084951 |
| 35 | LMTK2 | 1.32996243 |
| 36 | MAP3K1 | 1.30204931 |
| 37 | LATS2 | 1.28455883 |
| 38 | TYK2 | 1.26265787 |
| 39 | MAP2K6 | 1.26247465 |
| 40 | PTK6 | 1.24726520 |
| 41 | MAP3K14 | 1.22731354 |
| 42 | EEF2K | 1.22562171 |
| 43 | MET | 1.18604293 |
| 44 | ARAF | 1.16952375 |
| 45 | TGFBR2 | 1.12070860 |
| 46 | IRAK4 | 1.11346013 |
| 47 | LRRK2 | 1.11173755 |
| 48 | PKN2 | 1.10700772 |
| 49 | TAOK1 | 1.05658102 |
| 50 | ACVR1B | 1.04887690 |
| 51 | MAPK15 | 1.03274780 |
| 52 | KDR | 0.96698917 |
| 53 | ZAP70 | 0.96653391 |
| 54 | JAK2 | 0.95453771 |
| 55 | PDPK1 | 0.94047645 |
| 56 | JAK1 | 0.92087730 |
| 57 | PTK2 | 0.91625449 |
| 58 | IKBKB | 0.90522145 |
| 59 | PIK3CA | 0.90135638 |
| 60 | CSK | 0.86621042 |
| 61 | WNK1 | 0.86510644 |
| 62 | SCYL2 | 0.85456782 |
| 63 | FER | 0.84405594 |
| 64 | LIMK1 | 0.84042410 |
| 65 | SIK1 | 0.80971882 |
| 66 | SGK223 | 0.80189347 |
| 67 | SGK494 | 0.80189347 |
| 68 | CHUK | 0.79271541 |
| 69 | MATK | 0.78389972 |
| 70 | RIPK1 | 0.73840925 |
| 71 | PDGFRA | 0.72066177 |
| 72 | MYLK | 0.71150514 |
| 73 | PAK4 | 0.69352326 |
| 74 | TRPM7 | 0.69127388 |
| 75 | ABL2 | 0.68853253 |
| 76 | GRK1 | 0.68502371 |
| 77 | CDC42BPA | 0.67256652 |
| 78 | PIK3CG | 0.66852273 |
| 79 | ADRBK2 | 0.66842596 |
| 80 | IRAK2 | 0.66753212 |
| 81 | MAP2K1 | 0.65728145 |
| 82 | PDK1 | 0.65609268 |
| 83 | FES | 0.65319315 |
| 84 | IKBKE | 0.65288841 |
| 85 | STK38 | 0.64061381 |
| 86 | BTK | 0.63774096 |
| 87 | PRKAA2 | 0.59849221 |
| 88 | MAPK11 | 0.59483007 |
| 89 | BRAF | 0.57188041 |
| 90 | GRK7 | 0.56905619 |
| 91 | PRKG2 | 0.56600406 |
| 92 | CLK1 | 0.56361029 |
| 93 | MAP3K12 | 0.56347183 |
| 94 | KIT | 0.56323362 |
| 95 | MAP3K8 | 0.55939452 |
| 96 | IRAK1 | 0.55813162 |
| 97 | FLT3 | 0.55272801 |
| 98 | MTOR | 0.54000264 |
| 99 | MAP2K3 | 0.53697849 |
| 100 | SYK | 0.53626306 |
| 101 | MAP3K5 | 0.53531132 |
| 102 | STK10 | 0.53355394 |
| 103 | MAPKAPK5 | 0.52137636 |
| 104 | ITK | 0.51240805 |
| 105 | EIF2AK1 | 0.50762595 |
| 106 | GSK3A | 0.50554030 |
| 107 | PDK2 | 0.49870035 |
| 108 | MAP3K3 | 0.49627773 |
| 109 | PRKCI | 0.49378097 |
| 110 | MUSK | 0.49340117 |
| 111 | JAK3 | 0.49150718 |
| 112 | TIE1 | 0.48140678 |
| 113 | MAP3K10 | 0.47770127 |
| 114 | MAP3K11 | 0.47569010 |
| 115 | STK16 | 0.46922271 |
| 116 | NTRK1 | 0.45397989 |
| 117 | NME2 | 0.44680857 |
| 118 | RET | 0.44526847 |
| 119 | AKT3 | 0.44058562 |
| 120 | CAMKK1 | 0.43690689 |
| 121 | SGK3 | 0.42902981 |
| 122 | CSF1R | 0.42728305 |
| 123 | DAPK3 | 0.42441334 |
| 124 | PRKCD | 0.42353294 |
| 125 | MARK3 | 0.42114039 |
| 126 | MAPKAPK2 | 0.41721797 |
| 127 | LYN | 0.40479328 |
| 128 | EIF2AK3 | 0.38246711 |
| 129 | AKT2 | 0.37368478 |
| 130 | FGR | 0.37235468 |
| 131 | HCK | 0.36236163 |
| 132 | TESK1 | 0.35884914 |
| 133 | DYRK1B | 0.35829381 |
| 134 | MAP3K7 | 0.35662995 |
| 135 | CAMK2D | 0.35401319 |
| 136 | NME1 | 0.34931487 |
| 137 | BMX | 0.34530075 |
| 138 | NEK9 | 0.33291681 |
| 139 | TESK2 | 0.33256747 |
| 140 | MAP3K9 | 0.32597275 |
| 141 | LCK | 0.32425250 |
| 142 | CAMK1D | 0.31589803 |
| 143 | CAMK2G | 0.31143903 |
| 144 | CSNK1G3 | 0.30264584 |
| 145 | PRKD2 | 0.28682853 |
| 146 | RPS6KA2 | 0.26933260 |
| 147 | PRPF4B | 0.26622253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93930124 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.62992500 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51746330 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50687308 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49921073 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.37005235 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29806475 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.22291677 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07707451 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.05238768 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.04189952 |
| 12 | * Lysosome_Homo sapiens_hsa04142 | 2.03693904 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.01461659 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00002291 |
| 15 | * Other glycan degradation_Homo sapiens_hsa00511 | 1.94508150 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93781310 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.85683789 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79690502 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79453245 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.77524653 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76395633 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69780468 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.65804862 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62238205 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56073082 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55957797 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53162733 |
| 28 | Mineral absorption_Homo sapiens_hsa04978 | 1.50433153 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48391500 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48338837 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42564196 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41178155 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37009515 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31384336 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30830028 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27563752 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21650207 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19878737 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19218608 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17239011 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16321811 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11152785 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09827629 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04756200 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04363465 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04301169 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03324266 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03273234 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02040423 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.00726569 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97972312 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.97494728 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95884588 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93450160 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88306506 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88276881 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87416028 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.87004653 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.85018975 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83535099 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83407992 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83165242 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79856473 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78272303 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76586261 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.74693210 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74174643 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72183471 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67878931 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66675394 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66330172 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66219052 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65720967 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.65431853 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64724692 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64510023 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63619979 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62561966 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62067112 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62033910 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61417653 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58721953 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58468857 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58130438 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55364964 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54902672 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.53338321 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53136547 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53089705 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.48706839 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47154967 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46976245 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.44821401 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44170556 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42937148 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42127153 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42049119 |
| 98 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39159480 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38724085 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37926419 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37702284 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.35688165 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35625332 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35138374 |
| 105 | Proteasome_Homo sapiens_hsa03050 | 0.34945367 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33585393 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33232294 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32444514 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32050383 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.31467800 |
| 111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31317141 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30982268 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.30515330 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30257124 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29926200 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29665305 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28797610 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27989654 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27716214 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27703046 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26004504 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25257977 |

